Trilogy Cardiac TAVI System

JenaValve’s TAVI Trilogy™ system is indicated in patients with severe symptomatic native aortic regurgitation (AR) or severe symptomatic aortic stenosis (AS).

The JenaValve TAVI Trilogy™ system consists of:

  1. Trilogy™ transcatheter heart valve

                           SIZE 23                                                                                        SIZE 25                                                                                  SIZE 27             

                

  1. Delivery Catheter

    Facilitates catheter alignment of the THV within the native aortic valve and allows for simple, controlled deployment of the THV

  1. Introducer Sheath System/ dilator

    customized long pre-shaped sheath protects anatomy and valve locator technology during delivery. The dilator facilitates safe vascular access and deliverability of the introducer sheath

  1. Valve Loading Tools

Scarica la brochure
JenaValve is a medical device company developing the first transcatheter heart valve technology that is uniquely designed for the minimally invasive treatment of both severe aortic regurgitation and stenosis. JenaValve is passionate about providing our physician partners with cutting-edge technology aimed at improving the lives of our patients.